Literature DB >> 31047772

Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology.

Yongsheng Li1, Yunpeng Zhang2, Xia Li3, Song Yi4, Juan Xu5.   

Abstract

Advances in next-generation sequencing have identified thousands of genomic variants that perturb the normal functions of proteins, further contributing to diverse phenotypic consequences in cancer. Elucidating the functional pathways altered by loss-of-function (LOF) or gain-of-function (GOF) mutations will be crucial for prioritizing cancer-causing variants and their resultant therapeutic liabilities. In this review, we highlight the fundamental function of GOF mutations and discuss the potential mechanistic effects in the context of signaling networks. We also summarize advances in experimental and computational resources, which will dramatically help with studies on the functional and phenotypic consequences of mutations. Together, systematic investigations of the function of GOF mutations will provide an important missing piece for cancer biology and precision therapy.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gain-of-function mutations; driver mutations; signaling network

Mesh:

Substances:

Year:  2019        PMID: 31047772      PMCID: PMC6944532          DOI: 10.1016/j.tibs.2019.03.009

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  116 in total

1.  FoldUnfold: web server for the prediction of disordered regions in protein chain.

Authors:  Oxana V Galzitskaya; Sergiy O Garbuzynskiy; Michail Yu Lobanov
Journal:  Bioinformatics       Date:  2006-10-04       Impact factor: 6.937

2.  An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex.

Authors:  Megha A Desai; Heather D Webb; Leander M Sinanan; J Neel Scarsdale; Ninad M Walavalkar; Gordon D Ginder; David C Williams
Journal:  Nucleic Acids Res       Date:  2015-03-09       Impact factor: 16.971

3.  A High-Throughput Mutational Scan of an Intrinsically Disordered Acidic Transcriptional Activation Domain.

Authors:  Max V Staller; Alex S Holehouse; Devjanee Swain-Lenz; Rahul K Das; Rohit V Pappu; Barak A Cohen
Journal:  Cell Syst       Date:  2018-03-07       Impact factor: 10.304

4.  Functional correlates of mutation of the Asp32 and Gly34 residues of beta-catenin.

Authors:  Elayne Provost; Anthony McCabe; Jessica Stern; Isabel Lizardi; Thomas G D'Aquila; David L Rimm
Journal:  Oncogene       Date:  2005-04-14       Impact factor: 9.867

5.  Highly recurrent TERT promoter mutations in human melanoma.

Authors:  Franklin W Huang; Eran Hodis; Mary Jue Xu; Gregory V Kryukov; Lynda Chin; Levi A Garraway
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

6.  Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies.

Authors:  Roland W Pfaeffle; Chad S Hunter; Jesse J Savage; Mario Duran-Prado; Rachel D Mullen; Zachary P Neeb; Urs Eiholzer; Volker Hesse; Nadine G Haddad; Heike M Stobbe; Werner F Blum; Johannes F W Weigel; Simon J Rhodes
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

7.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

8.  ChIPBase v2.0: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data.

Authors:  Ke-Ren Zhou; Shun Liu; Wen-Ju Sun; Ling-Ling Zheng; Hui Zhou; Jian-Hua Yang; Liang-Hu Qu
Journal:  Nucleic Acids Res       Date:  2016-10-23       Impact factor: 16.971

9.  RMBase v2.0: deciphering the map of RNA modifications from epitranscriptome sequencing data.

Authors:  Jia-Jia Xuan; Wen-Ju Sun; Peng-Hui Lin; Ke-Ren Zhou; Shun Liu; Ling-Ling Zheng; Liang-Hu Qu; Jian-Hua Yang
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  An interactome perturbation framework prioritizes damaging missense mutations for developmental disorders.

Authors:  Siwei Chen; Robert Fragoza; Lambertus Klei; Yuan Liu; Jiebiao Wang; Kathryn Roeder; Bernie Devlin; Haiyuan Yu
Journal:  Nat Genet       Date:  2018-06-11       Impact factor: 38.330

View more
  7 in total

Review 1.  Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.

Authors:  Tandrima Mitra; Selvakumar Elangovan
Journal:  Mol Cell Biochem       Date:  2021-08-28       Impact factor: 3.396

Review 2.  dCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy.

Authors:  Lisa M Riedmayr; Klara S Hinrichsmeyer; Nina Karguth; Sybille Böhm; Victoria Splith; Stylianos Michalakis; Elvir Becirovic
Journal:  Nat Protoc       Date:  2022-02-07       Impact factor: 17.021

3.  e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks.

Authors:  Yongsheng Li; Brandon Burgman; Ishaani S Khatri; Sairahul R Pentaparthi; Zhe Su; Daniel J McGrail; Yang Li; Erxi Wu; S Gail Eckhardt; Nidhi Sahni; S Stephen Yi
Journal:  Nucleic Acids Res       Date:  2021-01-11       Impact factor: 16.971

4.  Gain and loss of function mutations in biological chemical reaction networks: a mathematical model with application to colorectal cancer cells.

Authors:  Sara Sommariva; Giacomo Caviglia; Michele Piana
Journal:  J Math Biol       Date:  2021-05-04       Impact factor: 2.259

Review 5.  Allele-specific genome targeting in the development of precision medicine.

Authors:  Junjiao Wu; Beisha Tang; Yu Tang
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556

6.  Analysis of missense variants in the human genome reveals widespread gene-specific clustering and improves prediction of pathogenicity.

Authors:  Mathieu Quinodoz; Virginie G Peter; Katarina Cisarova; Beryl Royer-Bertrand; Peter D Stenson; David N Cooper; Sheila Unger; Andrea Superti-Furga; Carlo Rivolta
Journal:  Am J Hum Genet       Date:  2022-02-03       Impact factor: 11.025

7.  Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells.

Authors:  Florence Prat; Jérôme Toutain; Julian Boutin; Samuel Amintas; Grégoire Cullot; Magalie Lalanne; Isabelle Lamrissi-Garcia; Isabelle Moranvillier; Emmanuel Richard; Jean-Marc Blouin; Sandrine Dabernat; François Moreau-Gaudry; Aurélie Bedel
Journal:  Stem Cell Reports       Date:  2020-08-13       Impact factor: 7.765

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.